Director of AIRemote
Sr. Director / VP Artificial Intelligence
BioSpace · Biopharma Consulting & Drug Development Services · 📍 United States
Syner-G BioPharma is hiring its inaugural enterprise AI leader to define strategy, build infrastructure from scratch, and drive AI adoption across drug development and commercialization functions.
Key responsibilities
- Define and own the enterprise AI vision, strategy, and multi-year roadmap
- Identify high-value AI use cases across Technology, Operations, Product, and other business units
- Design, deploy, and oversee ML models and MLOps practices
- Ensure data readiness and integrate AI solutions into core business processes
- Implement responsible AI principles and governance frameworks
- Align executive and cross-functional stakeholders on AI transformation goals
Requirements
- Deep expertise in AI and machine learning with hands-on model development experience
- Proven ability to define and execute enterprise AI strategy
- Experience with MLOps, data strategy, and production AI deployment
- Strong executive communication and stakeholder alignment skills
- Ability to operate with high autonomy in a greenfield environment
Signals
- ⚠ No salary or compensation details disclosed
- ⚠ Exact reporting structure not specified
- ⚠ Remote/hybrid/onsite policy not stated
- ⚠ HQ city not disclosed — geographic expectations unclear for a US-wide posting
- ✓ Explicitly the company's first enterprise AI hire — high strategic visibility
- ✓ Greenfield mandate with enterprise-wide scope and exec partnership
- ✓ Award-winning culture with three consecutive 'Best Places to Work' recognitions
- ✓ Meaningful mission in biopharma with real-world patient impact
- ✓ Title flexibility (Sr. Director to VP) suggests openness to right candidate over rigid hierarchy
Company history
The previous posting from 2026-05-30 carries identical language confirming this is the first-ever enterprise AI leader hire — this appears to be the same active search reposted, not a backfill, suggesting the role has not yet been filled and urgency may be increasing.